Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$233,530,829
-$148,765,314 QoQ
Shares Held
1,975,559
-35.0% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 79.95119356091112.ToString("F0")%
Shared 0.ToString("F0")%
None 20.04880643908889.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,975,559 | $233,530,829 | |
| 2 | HLN |
Haleon plc
|
14,674,518 | $146,891,925 | |
| 3 | VTRS |
Viatris Inc
|
8,545,196 | $115,445,597 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,323,264 | $70,813,086 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,116,311 | $57,714,079 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
564,360 | $43,399,284 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
892,666 | $42,981,867 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
703,528 | $23,265,670 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,530,829 | 1,975,559 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $382,296,143 | 3,038,437 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $394,746,046 | 2,697,827 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $229,362,214 | 1,470,742 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $106,760,377 | 648,408 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $43,612,939 | 267,679 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,819,288 | 19,548 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $26,261,680 | 152,498 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $29,677,250 | 178,306 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $103,533,031 | 706,469 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $150,041,898 | 1,011,814 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $358,699,192 | 2,086,795 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $627,334,828 | 3,326,448 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $298,727,372 | 1,224,142 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $274,918,547 | 1,416,084 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $170,952,873 | 917,326 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $182,888,610 | 1,161,345 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $31,845,344 | 192,419 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $782,034 | 4,729 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,215,764 | 81,843 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $39,194,183 | 333,029 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||